March 23, 2026 - THE SCIENCE NOTES

Infographic illustrating Mosunetuzumab as a bispecific CD20/CD3 antibody, showing T-cell engagement, B-cell targeting, mechanism of action, approvals timeline, and key facts about its use in follicular lymphoma, created by www.thesciencenotes.com

March 23, 2026 Cancer

Mosunetuzumab (Lunsumio): Mechanism, Pharmacology, Uses & Side Effects

Explore a detailed guide on Mosunetuzumab, including mechanism, pharmacology, clinical use, safety, and FDA approval for follicular lymphoma. Read more

S	M	T	W	T	F	S
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30	31